<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Cambridge Institute for Medical Research</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3C58F31A-E143-46EE-9314-B6EF1158AA8B"><gtr:id>3C58F31A-E143-46EE-9314-B6EF1158AA8B</gtr:id><gtr:firstName>Jennifer</gtr:firstName><gtr:otherNames>Amy</gtr:otherNames><gtr:surname>Dickens</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1000277"><gtr:id>5C49FF29-2767-4778-B6D5-B0DD06B1C1D0</gtr:id><gtr:title>Epithelial and macrophage dysfunction in alpha1-antitrypsin deficiency</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1000277</gtr:grantReference><gtr:abstractText>Alpha-1-antitrypsin is produced and secreted from the liver. It plays an important role in controlling inflammation and preventing tissue damage, particularly in the lung. A common genetic mutation in the 1-antitrypsin gene causes molecules of 1-antitrypsin to stick together, forming polymers. Polymers are trapped in liver cells causing liver damage. The amount of 1-antitrypsin in the blood is reduced and cannot perform its usual function; this causes lung inflammation and emphysema. Alpha-1-antitrypsin is also produced in cells that line the lung and in white blood cells. I propose to assess whether the retention of polymers in these cells causes them to malfunction and so cause further lung damage. I will do this by expressing the mutant protein in cell lines and assessing whether this causes them to malfunction and release inflammatory molecules. I will then take samples from the lungs of individuals with 1-antitrypsin deficiency to see if the cells are dysfunctional in humans. This will allow me to assess whether the retention of polymers of mutant 1-antitrypsin in lung cells contributes to lung inflammation and hence emphysema in individuals with 1-antitrypsin deficiency.</gtr:abstractText><gtr:technicalSummary>1-antitrypsin is the most abundant circulating protease inhibitor. The common severe Z allele (Glu342Lys) causes the protein to form ordered polymers that are retained within the endoplasmic reticulum (ER) of hepatocytes. These polymers do not activate the unfolded protein response (UPR) but lead to activation of NF-kB. This in turn causes liver disease whilst the lack of circulating 1-antitrypsin predisposes the PiZZ homozygote to early onset emphysema. Z 1-antitrypsin is synthesised and secreted by monocytes/macrophages and bronchial and alveolar epithelial cells within the lung. It is unknown whether the accumulation of polymers within these cells also activates NF-kB as they do in the liver. I propose to evaluate this with 2 specific aims: (i) to determine the effect of intracellular polymers on epithelial cells in vitro and (ii) to determine the effect of intracellular polymers on lung epithelium and monocytes/macrophages in vivo. 

I will firstly generate alveolar (A549) and bronchial epithelial cell lines (BEAS-2B) that conditionally express wildtype and Z 1-antitrypsin under the control of a Tet-ON promotor. I will then assess whether the expression of wildtype or Z 1-antitrypsin causes the activation of the unfolded protein response (by measuring BiP, Grp94, GADD34 and CHOP protein levels, XBP1 mRNA splicing and ATF6 reporter activation), ER calcium release (Fluo-4 fluorescence), NF- B signalling (NF- B subunit protein levels, subcellular localisation and reporter activation) and the release of inflammatory cytokines such as IL-6 and IL-8 by sandwich ELISA. In the second aim I will purify monocytes from the blood of individuals with PiZZ 1-antitrypsin deficiency and PiMM controls. I will assess whether the monocytes that express Z 1-antitrypsin show evidence of ER stress, calcium release and a greater release of inflammatory cytokines. Finally, I will bronchoscope and take bronchial biopsies from individuals with PiZZ 1-antitrypsin deficiency and PiMM controls to assess whether epithelial cells in vivo show similar changes to those see in vitro.

Taken together these experiments will allow me to determine whether the accumulation of Z 1-antitrypsin causes epithelial and monocyte/macrophage dysfunction in 1-antitrypsin deficiency. If so, then this would provide novel insights into the pathogenesis of the associated emphysema.</gtr:technicalSummary><gtr:fund><gtr:end>2014-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>193232</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Primary lung epithelial cell collaboration</gtr:description><gtr:id>0FDBDFB3-EAD4-432A-A0E1-D79DB8475389</gtr:id><gtr:impact>Human Molecular Genetics publication</gtr:impact><gtr:outcomeId>54494c79c4e521.12668778-1</gtr:outcomeId><gtr:partnerContribution>Provision of, and expertise in, primary cell culture</gtr:partnerContribution><gtr:piContribution>Expertise on measuring ER stress and alpha-1-antitrypsin cellular expression</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sackler Studentship Award</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>404895C6-8D05-40C6-ACD7-7F076A7030B2</gtr:id><gtr:outcomeId>EVTUHzpkKVh</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Created for the study of wildtype and mutant alpha-1-antitrypsin expression in alveolar epithelium, particularly the effect on intracellular accumulation and intracellular stress signalling pathways. The TetON system allows inducible, stable expression from a clonal cell line. Previously done with other cell lines but never lung epithelium which has different expression levels in vivo.</gtr:description><gtr:id>EF05F870-5FBC-47CA-9B6C-1E554C2917EF</gtr:id><gtr:impact>Allowed study of intracellular stress signalling pathways and alpha-1-antitrypsin expression levels in lung epithelium and has provided insights into the differences between alveolar expression and hepatocyte expression.</gtr:impact><gtr:outcomeId>XfxT6F8rd44</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>alpha-1-antitrypsin TetON alveolar epithelial cells</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>cell line expression plasmid containing Halotag_ alpha-1-antitrypsin</gtr:description><gtr:id>3B040E55-92FC-4866-B082-8FA912FBF2F1</gtr:id><gtr:impact>can be used to perform live cell imaging pulse chase experiments during which newly synthesised protein can be labelled sequentially</gtr:impact><gtr:outcomeId>HjaFKqhH7sT</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Halotag alpha-1-antitrypsin plasmids</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>cell line expression plasmid containing YFP-tagged wild type (M) or mutant (Z) alpha-1-antitrypsin</gtr:description><gtr:id>3A2E628A-EF4E-4B54-AB72-02805969EA42</gtr:id><gtr:impact>can be used to follow protein accumulation and secretion in real time to provide information on dynamics of protein processing in cell line models</gtr:impact><gtr:outcomeId>RNi8UU59PNB</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>fluorescent tagged alpha-1-antitrypsin</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>26D0E313-998F-46B7-BF70-6E0E3BA479CE</gtr:id><gtr:title>The endoplasmic reticulum remains functionally connected by vesicular transport after its fragmentation in cells expressing Z-a1-antitrypsin.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430d8e459ce88909a545110552e678c5"><gtr:id>430d8e459ce88909a545110552e678c5</gtr:id><gtr:otherNames>Dickens JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>5890528448b509.46791750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A0A5864-771F-4CAF-A61E-94F6E0845C35</gtr:id><gtr:title>Altered native stability is the dominant basis for susceptibility of a1-antitrypsin mutants to polymerization.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a97c91ca9350b38134a6403aba65587"><gtr:id>5a97c91ca9350b38134a6403aba65587</gtr:id><gtr:otherNames>Irving JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>544949462a8343.39196450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39CFACBA-E509-4CA6-B9CF-BCDB4EEFFD3F</gtr:id><gtr:title>A single-chain variable fragment intrabody prevents intracellular polymerization of Z a1-antitrypsin while allowing its antiproteinase activity.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e91db47f6a14985649e44551f7e7f2"><gtr:id>b8e91db47f6a14985649e44551f7e7f2</gtr:id><gtr:otherNames>Ord??ez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>56dd9d8b6300a4.18778801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0694792-0306-40CC-92BD-EE7BDFEBA356</gtr:id><gtr:title>Increased ERK signalling promotes inflammatory signalling in primary airway epithelial cells expressing Z a1-antitrypsin.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/534c7795a0239195bc650835e9927b86"><gtr:id>534c7795a0239195bc650835e9927b86</gtr:id><gtr:otherNames>van 't Wout EF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>54494ad7905d49.96156318</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C224A84C-49B5-4DCC-BDAB-E413793CB1E0</gtr:id><gtr:title>Reactive centre loop mutants of a-1-antitrypsin reveal position-specific effects on intermediate formation along the polymerization pathway.</gtr:title><gtr:parentPublicationTitle>Bioscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/deb0f4a6c8f3d23b81e23b1b226bebd5"><gtr:id>deb0f4a6c8f3d23b81e23b1b226bebd5</gtr:id><gtr:otherNames>Haq I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0144-8463</gtr:issn><gtr:outcomeId>QFvKEcRyW4N</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2D46CA7-1CB6-4F2F-8773-78F6941959E4</gtr:id><gtr:title>Circulating polymers in a1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/455a84b93aefbf86b2bdcb87b72facd1"><gtr:id>455a84b93aefbf86b2bdcb87b72facd1</gtr:id><gtr:otherNames>Tan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>544949a9691d08.50151615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8572541-6979-4509-9D53-5883B5069AEC</gtr:id><gtr:title>Characterising the association of latency with a(1)-antitrypsin polymerisation using a novel monoclonal antibody.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/455a84b93aefbf86b2bdcb87b72facd1"><gtr:id>455a84b93aefbf86b2bdcb87b72facd1</gtr:id><gtr:otherNames>Tan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>56dd9d8b8acbc1.75617423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC12ABA9-85E2-47BF-A9EA-C372CD64B430</gtr:id><gtr:title>New Concepts in Alpha-1 Antitrypsin Deficiency Disease Mechanisms.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7c6bfc1bae97372046055e2e769195"><gtr:id>6b7c6bfc1bae97372046055e2e769195</gtr:id><gtr:otherNames>Marciniak SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>5890528470a657.18678364</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E0A639E-EB62-4A39-92BF-56741C0D5DEB</gtr:id><gtr:title>The molecular and cellular pathology of a1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>Trends in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f7ec6cd45f2cd59b79537e29826f8d6"><gtr:id>2f7ec6cd45f2cd59b79537e29826f8d6</gtr:id><gtr:otherNames>Gooptu B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-4914</gtr:issn><gtr:outcomeId>54494b632f4967.32295474</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000277</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>